Concepedia

Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database

Kie Abe, Yuhei Chiba, Saki Hattori, Asuka Yoshimi, Takeshi Asami, Omi Katsuse, Akira Suda, Akitoyo Hishimoto

Journal of the Neurological Sciences · 2020 · 37 citations · 27 references

DOI

Concepts

References

27

Mild Cognitive Impairment

Ronald C. Petersen, Glenn E. Smith, Stephen C. Waring et al. · Archives of Neurology · 1999 · 9K citations

, , +17

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Leslie M. Shaw, Hugo Vanderstichele, Małgorzata Knapik-Czajka et al. · Annals of Neurology · 2009 · 2.1K citations · Full text

, , +17

Matrix Metalloproteinase-9 Is Required for Hippocampal Late-Phase Long-Term Potentiation and Memory

Vanja Nagy, Ozlem Bozdagi, Anna Matynia et al. · Journal of Neuroscience · 2006 · 490 citations · Full text

, , +17

Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ

Ping Yan, Haowei Song, Ke‐Jie Yin et al. · Journal of Biological Chemistry · 2006 · 363 citations · Full text

, , +17

Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade

Martín A. Bruno, A. Claudio Cuello · Proceedings of the National Academy of Sciences · 2006 · 345 citations · Full text

, , +15